William Kuochang Wei

US Patent:

8644153, Feb 4, 2014

Filed:

Jul 31, 2007

Appl. No.:

11/831305

Inventors:

Ciprian P. Popoviciu - Raleigh NC, US
John M. Gavin - Raleigh NC, US
William J. Wei - Raleigh NC, US
Mohamed Khalid - Cary NC, US

Assignee:

Cisco Technology, Inc. - San Jose CA

International Classification:

H04B 7/185

US Classification:

370235, 370229

Abstract:

Methods and apparatus for providing a mediation device infrastructure that allows a mobile node to be tapped while roaming among and within service providers are disclosed. In one embodiment, a method includes determining when a node that is tapped by a first mediation device has moved from a first domain associated with the first mediation device into a second domain associated with a second mediation device. A first packet is sent to the second mediation device if the node has moved. The first packet provides an indication that the second mediation device is to tap the node. The method also includes opening a call data channel to the second mediation device, and receiving information from the second mediation device on the call data channel that is obtained by the second mediation device from the node. Finally, the method includes providing the information to the first mediation device.

US Patent:

20040062787, Apr 1, 2004

Filed:

Aug 11, 2003

Appl. No.:

10/450344

Inventors:

William Daley - Morris Plains NJ, US
Randy Webb - Flemington NJ, US
Ann Comfort - New City NY, US
Santo Fleres - Hillsborough NJ, US
Alan Royce - Saylorsburg PA, US
William Wei - Belle Mead NJ, US

International Classification:

A61F002/00

US Classification:

424/423000

Abstract:

The present invention is directed to an improved sustained release drug delivery device comprising a drug core, a unitary cup, and a permeable plug.

US Patent:

20080287412, Nov 20, 2008

Filed:

Jul 28, 2008

Appl. No.:

12/180979

Inventors:

Ann R. Comfort - New City NY, US
William L. Daley - Morris Plains NJ, US
Santo J. Fleres - Hillsborough NJ, US
Alan E. Royce - Saylorsburg PA, US
Randy L. Webb - Flemington NJ, US
William S. Wei - Belle Mead NJ, US

International Classification:

A61K 31/55
B05D 3/02
A61P 9/12

US Classification:

51421007, 427 214

Abstract:

The present invention especially relates to the use of a combination comprising(1) an ACEI selected from the group consisting of benazepril, benazeprilat, and pharmaceutically acceptable salts thereof, and(2) amlodipine or pharmaceutically acceptable salt thereof,for the manufacture a medicament for the treatment or prevention or delay of progression of a condition selected from the group consisting of hypertension, congestive heart failure, angina, myocardial infarction, artherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, blood pressure-related cerebrovasular disease, stroke, pulmonary disease or pulmonary hypertension and headache;wherein(i) the amount of amlodipine or a pharmaceutically acceptable salt thereof corresponds to 6 about mg to 40 about mg of the free base and(ii) the amount of the ACE inhibitor or a pharmaceutically thereof corresponds to 20 about mg to 160 about mg of benazepril hydrochloride.

US Patent:

20080317019, Dec 25, 2008

Filed:

Jun 19, 2007

Appl. No.:

11/765094

Inventors:

Ciprian P. Popoviciu - Raleigh NC, US
Mohamed Khalid - Cary NC, US
John M. Gavin - Raleigh NC, US
William J. Wei - Raleigh NC, US

International Classification:

H04L 12/28

US Classification:

370389

Abstract:

In an embodiment, a care-of address associated with a first node coupled to a communications network via an access node is received. The care-of address may be contained in a notification message sent by a home agent associated with the first node or by a binding update message sent by the first agent. The access node is identified using the care-of address. A request to tap communications associated with the first node at the access node is generated and the request is forwarded to the access node to cause communications associated with the first node to be tapped at the access node.

US Patent:

20100196467, Aug 5, 2010

Filed:

Apr 16, 2010

Appl. No.:

12/761450

Inventors:

William Lionel Daley - Morris Plains NJ, US
Randy Lee Webb - Flemington NJ, US
Ann Reese Comfort - New City NY, US
Santo Joseph Fleres - Hillsborough NJ, US
Alan Edward Royce - Saylorsburg PA, US
William Shifeng Wei - Belle Mead NJ, US

International Classification:

A61K 31/55
A61K 9/48
A61K 9/66
A61P 9/12
B05D 3/00

US Classification:

424455, 51421207, 424456, 427 214

Abstract:

The present invention especially relates to the use of a combination comprising(1) an ACEI selected from the group consisting of benazepril, benazeprilat, and pharmaceutically acceptable salts thereof, and(2) amlodipine or pharmaceutically acceptable salt thereof, for the manufacture a medicament for the treatment or prevention or delay of progression of a condition selected from the group consisting of hypertension, congestive heart failure, angina, myocardial infarction, artherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, blood pressure-related cerebrovasular disease, stroke, pulmonary disease or pulmonary hypertension and headache;wherein(i) the amount of amlodipine or a pharmaceutically acceptable salt thereof corresponds to 6 about mg to 40 about mg of the free base and(ii) the amount of the ACE inhibitor or a pharmaceutically thereof corresponds to 20 about mg to 160 about mg of benazepril hydrochloride.

Author:

William Wei

ISBN #:

0472100572

Author:

William Wei

ISBN #:

0782144357